PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan, hiro_nakase@sapmed.ac.jp.\', \'Division of Gastroenterology, Department of Medicine, Iwate Medical University, Morioka, Japan.\', \'Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.\', \'Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.\', \'Department of Gastroenterology and Hepatology, Toho University Sakura Medical Center, Chiba, Japan.\', \'Department of Gastroenterology, Fujita Health University School of Medicine, Aichi, Japan.\', \'Department of Gastroenterology, Faculty of Medicine, Shimane University, Izumo, Japan.\', \'Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan.\', \'Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1159/000510502
?:doi
?:hasPublicationType
?:journal
  • Digestion
is ?:pmid of
?:pmid
?:pmid
  • 32892197
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.922
?:rankingScore_hIndex
  • 68
is ?:relation_isRelatedTo_publication of
?:title
  • Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all